Phase 1 trials of BI 764198, a transient receptor potential channel 6 inhibitor, in healthy volunteers and participants with kidney impairment.

BI 764198 - Boehringer Ingelheim

midazolam hydrochloride - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/40455255

Armin Schultz; Atef Halabi; Friedeborg Seitz; Hauke S Wülfrath; Katrien Lemmens; Maximilian T Lobmeyer; Nima Soleymanlou; Silke Retlich; Wansuk Choi

Jun 2, 2025